143 related articles for article (PubMed ID: 34402476)
21. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study.
Wong YJ; Kew GS; Tan PS; Chen Z; Putera M; Yip WA; Ang TL; Fock KM; Lee GH; Hsiang J; Huang DQ; Kwek A; Muthiah MD; Kumar R; Tan M; Tan J; Thurairajah PH; Teo EK; Tai BC; Lim SG
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101598. PubMed ID: 33780835
[TBL] [Abstract][Full Text] [Related]
22. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
Ismail M
Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
[TBL] [Abstract][Full Text] [Related]
23. Combining Spleen Diameter and the Baveno VI Criteria Assessed by 2-Dimensional Shear Wave Elastography to Rule Out High-Risk Varices.
Zhang Z; Zhou H; Duan K; Chen F; Zhang J; Sang L; Zhu X; Yu M
Ultrasound Q; 2024 Jun; 40(2):104-110. PubMed ID: 38470974
[TBL] [Abstract][Full Text] [Related]
24. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
[TBL] [Abstract][Full Text] [Related]
25. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
27. Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study.
El-Kassas M; Elakel W; Alboraie M; Ezzat R; Abdelhakam S; Hassany M; Ali-Eldin Z; Sherief AF; Yosry A; El-Serafy M; El-Sayed MH; Waked I; Doss W; Esmat G;
Arab J Gastroenterol; 2022 May; 23(2):120-124. PubMed ID: 35473688
[TBL] [Abstract][Full Text] [Related]
28. Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
Calvaruso V; Cacciola I; Licata A; Madonia S; Benigno R; Petta S; Bronte F; Conte E; Malizia G; Bertino G; Distefano M; Montineri A; Digiacomo A; Alaimo G; Cacopardo B; Davì A; Guarneri L; Scalisi I; Colletti P; Cartabellotta F; Portelli V; Prestileo T; Averna A; Iacobello C; Mondello L; Scifo G; Russello M; Squadrito G; Raimondo G; Cammà C; Craxì A; Di Marco V;
Am J Gastroenterol; 2019 Aug; 114(8):1275-1282. PubMed ID: 31135449
[TBL] [Abstract][Full Text] [Related]
29. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.
Bai W; Abraldes JG
Curr Opin Gastroenterol; 2022 May; 38(3):206-215. PubMed ID: 35645017
[TBL] [Abstract][Full Text] [Related]
31. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
[TBL] [Abstract][Full Text] [Related]
32. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis.
Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A
Indian J Gastroenterol; 2024 Jun; 43(3):609-615. PubMed ID: 37840111
[TBL] [Abstract][Full Text] [Related]
33. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
[TBL] [Abstract][Full Text] [Related]
34. RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Calvaruso V; Celsa C; D'Ambrosio R; Simone F; Petta S; Cacciola I; Enea M; Battaglia S; Pandolfo A; Licata M; Degasperi E; Cabibbo G; Di Marco L; Pennisi G; Borghi M; Di Martino V; Filomia R; Abdel-Hadi Y; Crapanzano L; Raimondo G; Lampertico P; Craxì A; Cammà C; Di Marco V
Am J Gastroenterol; 2022 Nov; 117(11):1816-1824. PubMed ID: 35973181
[TBL] [Abstract][Full Text] [Related]
35. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
[TBL] [Abstract][Full Text] [Related]
36. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Wu S; Shi Y; Chen S; Kong Y; Ma H; Ou X; Jia J; You H
Liver Int; 2021 Feb; 41(2):369-377. PubMed ID: 33277803
[TBL] [Abstract][Full Text] [Related]
37. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
[TBL] [Abstract][Full Text] [Related]
38. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
[TBL] [Abstract][Full Text] [Related]
39. Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study.
Protopapas AA; Mylopoulou T; Papadopoulos VP; Vogiatzi K; Goulis I; Mimidis K
Ann Gastroenterol; 2020; 33(1):87-94. PubMed ID: 31892803
[TBL] [Abstract][Full Text] [Related]
40. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
